Sterling Consolidated Corp. STCC
Last Post: 11/29/2018 11:18:53 AM
Board Marks: 4
Posts Today: 0
Board Views Today: 194
10/25/2016 11:32:05 AM
10/25/2016 11:31:12 AM
10/25/2016 11:30:32 AM
10/24/2016 1:51:05 PM
10/24/2016 1:50:39 PM
10/24/2016 1:50:15 PM
10/24/2016 1:49:48 PM
10/24/2016 1:49:21 PM
10/24/2016 1:48:58 PM
10/24/2016 12:32:28 PM
10/24/2016 12:31:44 PM
10/24/2016 12:31:11 PM
10/24/2016 11:47:15 AM
10/24/2016 11:46:09 AM
10/24/2016 11:45:21 AM
10/21/2016 2:28:20 PM
10/21/2016 2:03:45 PM
10/21/2016 2:03:22 PM
10/21/2016 2:02:39 PM
10/21/2016 2:02:10 PM
10/21/2016 1:01:13 PM
10/21/2016 1:00:21 PM
10/21/2016 12:59:44 PM
10/21/2016 12:13:01 PM
10/21/2016 12:11:45 PM
10/21/2016 12:11:11 PM
10/20/2016 2:24:55 PM
10/20/2016 2:23:49 PM
10/20/2016 2:18:31 PM
10/20/2016 2:17:50 PM
10/20/2016 2:16:58 PM
10/20/2016 2:15:53 PM
10/20/2016 2:15:04 PM
10/20/2016 2:14:28 PM
10/20/2016 2:13:06 PM
10/20/2016 1:27:39 PM
10/20/2016 1:26:49 PM
10/20/2016 1:26:18 PM
10/20/2016 12:23:41 PM
10/20/2016 12:22:48 PM
10/20/2016 12:21:53 PM
10/20/2016 11:43:44 AM
10/20/2016 11:42:38 AM
10/20/2016 11:41:46 AM
10/19/2016 12:29:48 PM
10/19/2016 11:24:30 AM
10/19/2016 11:23:12 AM
10/19/2016 11:22:16 AM
10/19/2016 9:53:19 AM
10/19/2016 9:51:33 AM
Recent Articles
- SKYWORTH Launches Revolutionary Matte Screen Ultra TV Series
- Exciting Advances in Lung Cancer Treatment with Sacituzumab Tirumotecan
- MoonLake Immunotherapeutics: A Call to Action for Investors
- Investors Urged to Act Quickly in PubMatic Class Action Suit
- Tragic Cargo Plane Incident at Hong Kong Airport Sparks Concerns
- Christine Lagarde's Insight: Upcoming Tariff Effects on U.S. Consumers
- Insights on the Upcoming Financial Street Forum in Beijing
- Antengene Advances ATG-022: Promising Clinical Outcomes Revealed
- Investigation Announcement for Baxter International Investors
- Cytokinetics Investors: Secure Representation Before Deadline
- Jasper Therapeutics Investors: Important Class Action Deadline Ahead
- Mesoblast Limited Reports Significant Revenue Growth After Ryoncil Launch
- CStone Pharmaceuticals Shares Promising Phase I Results for CS2009
- Ascletis Completes Enrollment in Phase IIa Study of ASC30.
- Innovations in Pancreatic Cancer Treatment with Satri-cel
- Cambodia's Techo International Airport: A Gateway to Growth
- Record Growth in Q2 Revenues Enhances Mesoblast's Market Position
- Faraday Future's Vision: Accelerating Towards FX Super One Launch
- IZERVAY™ Delivers Long-Term Benefits for Geographic Atrophy Patients
- Clover Biopharmaceuticals Names Nicholas Jackson as President
- Dr. Luke Wainscoat Brings Expertise to The Brattle Group
- Kering and L'Oréal Unite to Transform Luxury Beauty Sector
- Kering and L’Oréal: A New Era in Luxury Beauty and Wellness
- Kering Partners with L'Oréal to Transform Luxury Beauty Sector
- Alice Walton and Elon Musk: Giants of Wealth in 2025
- Clarins and V Magazine Host a Glamorous Golden Hour Event
- Sobi Adjusts Revenue Forecast for 2025 Amid Strong Q3 Growth
- Sobi Updates Full-Year Outlook and Q3 2025 Financial Report
- Exploring NB HASH and the Transformation of Wealth Today
- Kevin Hart's Journey From Investment Missteps to Business Success
- BlackRock's Strategic Shift: The Future of Investment in RWA
- Major Contract Termination Announced by Vantage Drilling
- Deadline Approaches for Dow Inc. Investors Amid Legal Action
- Important Update for Cepton, Inc. Investors on Class Action
- Target and Walmart Thrive Amid Collectible Card Sales Surge
- Snap Investors Urged to Consider Leading Legal Action
- Unlocking Wealth Potential: The RWA Revolution Explained
- Embracing Real-World Assets with NB HASH for Sustainable Growth
- Nutex Health Investors Can Join Class Action Against Company
- Potential Legal Action for Baxter International Investors
- Solidarity in Aviation: Airline Workers Support Controllers
- Class Action Lawsuit Against MoonLake Immunotherapeutics Investors
- Promising Outcomes Unveiled from HARMONi-6 Clinical Study
- Exploring Cadonilimab's Promising Results in Advanced Gastric Cancer
- Tech Giants Reshape Manufacturing Strategies Amid Market Shifts
- Promising Findings on Subcutaneous Amivantamab for Cancer
- Vivace Therapeutics Reports Promising Results for VT3989 Therapy
- iOncologi's Patent Enhances Cancer Treatment with mRNA Breakthrough
- Innovative Subcutaneous Therapy Shows Promise in Cancer Treatment
- New Breakthrough Data from Novartis on Prostate Cancer Treatment
